Asenapine

Imran Qureshi, PharmD, BCPP

INDICATIONS

FDA

  • Schizophrenia
  • Bipolar I disorder as maintenance monotherapy or adjunctive therapy to lithium or valproate
  • Acute monotherapy for treatment of mania or mixed episodes (adults and pediatrics)
  • Note: Transdermal patch only has schizophrenia indication.

There's more to see -- the rest of this topic is available only to subscribers.

© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.